These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34242809)

  • 21. The Sars-Cov-2 Pandemic and the Brave New Digital World of Environmental Enrichment to Prevent Brain Aging and Cognitive Decline.
    Hampel H; Vergallo A
    J Prev Alzheimers Dis; 2020; 7(4):294-298. PubMed ID: 32920634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cross-talk between long COVID-19 and Alzheimer's disease.
    Pszczołowska M; Walczak K; Misków W; Antosz K; Batko J; Karska J; Leszek J
    Geroscience; 2024 Jun; 46(3):2885-2899. PubMed ID: 38393535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interference between SARS-COV-2 and Alzheimer's disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic.
    Mansour HM
    Ageing Res Rev; 2024 Feb; 94():102195. PubMed ID: 38244862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia.
    Holder K; Reddy PH
    Neuroscientist; 2021 Aug; 27(4):331-339. PubMed ID: 32981462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer's disease.
    Chen J; Chen J; Lei Z; Zhang F; Zeng LH; Wu X; Li S; Tan J
    Transl Psychiatry; 2023 Dec; 13(1):396. PubMed ID: 38104129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia.
    Ramos C; Madrigal C; Aguirre-Acevedo DC; Giraldo-Chica M; Acosta-Baena N; Aponte C; Aguillón D; Gómez M; Espinosa A; Madrigal L; Uribe C; Saldarriaga A; Alzate D; Ruiz A; Andrade A; Lopez H; Langbaum JB; Sink KM; Reiman EM; Tariot PN; Ríos-Romenets S; Lopera F
    J Alzheimers Dis; 2023; 95(3):1091-1106. PubMed ID: 37638430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Home-Based Care for People with Alzheimer's Disease and Related Dementias (ADRD) during COVID-19 Pandemic: From Challenges to Solutions.
    Sm-Rahman A; Lo CH; Ramic A; Jahan Y
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33322696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Neuropathological Impacts of COVID-19: Challenges and Alternative Treatment Options for Alzheimer's Like Brain Changes on Severely SARS-CoV-2 Infected Patients.
    Rahman MR; Akter R; Neelotpol S; Mayesha II; Afrose A
    Am J Alzheimers Dis Other Demen; 2023; 38():15333175231214974. PubMed ID: 37972355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of diet and exercise in aging, Alzheimer's disease, and other chronic diseases.
    Khemka S; Reddy A; Garcia RI; Jacobs M; Reddy RP; Roghani AK; Pattoor V; Basu T; Sehar U; Reddy PH
    Ageing Res Rev; 2023 Nov; 91():102091. PubMed ID: 37832608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemic.
    Meyers EA; Amouyel P; Bovenkamp DE; Carrillo MC; De Buchy GD; Dumont M; Fillit H; Friedman L; Henderson-Begg G; Hort J; Murtishaw A; Oakley R; Panchal M; Rossi SL; Sancho RM; Thienpont L; Weidner W; Snyder HM
    Alzheimers Dement; 2022 May; 18(5):1067-1070. PubMed ID: 34596318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Awareness of the COVID-19 Outbreak and Resultant Depressive Tendencies in Patients with Severe Alzheimer's Disease.
    Tsugawa A; Sakurai S; Inagawa Y; Hirose D; Kaneko Y; Ogawa Y; Serisawa S; Takenoshita N; Sakurai H; Kanetaka H; Hirao K; Shimizu S
    J Alzheimers Dis; 2020; 77(2):539-541. PubMed ID: 32925073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential neurobiological links between social isolation and Alzheimer's disease risk.
    Drinkwater E; Davies C; Spires-Jones TL
    Eur J Neurosci; 2022 Nov; 56(9):5397-5412. PubMed ID: 34184343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resilience of Alzheimer's Disease to COVID-19.
    Li J; Long X; Huang H; Tang J; Zhu C; Hu S; Wu J; Li J; Lin Z; Xiong N
    J Alzheimers Dis; 2020; 77(1):67-73. PubMed ID: 32804094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future.
    Mok VCT; Pendlebury S; Wong A; Alladi S; Au L; Bath PM; Biessels GJ; Chen C; Cordonnier C; Dichgans M; Dominguez J; Gorelick PB; Kim S; Kwok T; Greenberg SM; Jia J; Kalaria R; Kivipelto M; Naegandran K; Lam LCW; Lam BYK; Lee ATC; Markus HS; O'Brien J; Pai MC; Pantoni L; Sachdev P; Skoog I; Smith EE; Srikanth V; Suh GH; Wardlaw J; Ko H; Black SE; Scheltens P
    Alzheimers Dement; 2020 Nov; 16(11):1571-1581. PubMed ID: 32789951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
    Zhao Y; Li W; Lukiw W
    Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
    Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
    Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Action of the Purinergic and Cholinergic Anti-inflammatory Pathways on Oxidative Stress in Patients with Alzheimer's Disease in the Context of the COVID-19 Pandemic.
    Simões JLB; Sobierai LD; Leal IF; Dos Santos MVR; Coiado JV; Bagatini MD
    Neuroscience; 2023 Feb; 512():110-132. PubMed ID: 36526078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing Clinical Trials for Alzheimer's Disease During the COVID-19 Crisis: Experience at Fundació ACE in Barcelona, Spain.
    Abdelnour C; Esteban de Antonio E; Pérez-Cordón A; Lafuente A; Buendía M; Pancho A; Jofresa S; Aguilera N; Ibarria M; Cuevas R; Cañada L; Calvet A; Diego S; González-Pérez A; Orellana A; Montrreal L; de Jorge L; Marquié M; Benaque A; Gurruchaga M; Tárraga L; Ruiz A; Boada M;
    J Alzheimers Dis; 2020; 77(4):1805-1813. PubMed ID: 32986671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.